Avience Biomedicals is set to finalize share allotment for its initial public offering on Tuesday, June 23, following a bidding period that closed Monday.
The SME IPO, which opened on June 18, attracted a staggering 385 times subscription, reflecting strong investor demand for the biotechnology firm's equity.
The company is scheduled to list on the NSE SME platform this Thursday.
Investors who applied during the bidding window can now check their allotment status online through the registrar's portal or their trading applications.
The high subscription multiple suggests significant grey market premium potential, a common indicator of listing day volatility for oversubscribed SME issues.
This development adds to a busy week for Indian SME IPOs.